Stock listing
BSE:EPIGRAL Epigral Ltd Share Price
Indian listing (BSE) of Epigral Ltd · home listing NSE:EPIGRAL
Follow Epigral Ltd into a list and get an email when it puts out news.
Home listing price · NSE:EPIGRAL
₹928.30 INR -16.00 (-1.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:EPIGRAL
- Day range
- ₹925.00 – ₹959.95 INRNov 20, 2026
- Volume
- 44,005 sharesNov 20, 2026
- Market cap
- ₹40.05B INRAt the close on Nov 20, 2026 · price × 43.14M shares outstanding
- 52-week range
- ₹807.00 – ₹1,535.20 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹56.83M INRMedian day 33,098 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:EPIGRAL · Home | ₹928.30 INR | -16.00 (-1.7%) | 44,005 | ₹945.15 | ₹959.95 | ₹925.00 | ₹944.30 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:EPIGRAL · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹928.30 | -16.00 | -1.7% | ₹945.15 | ₹959.95 | ₹925.00 | 44,005 | |
| ₹944.30 | -3.30 | -0.3% | ₹947.20 | ₹949.00 | ₹927.25 | 12,154 | |
| ₹947.60 | -1.45 | -0.2% | ₹944.35 | ₹961.05 | ₹937.50 | 24,781 | |
| ₹949.05 | -1.65 | -0.2% | ₹948.10 | ₹950.00 | ₹935.00 | 17,711 | |
| ₹950.70 | +15.30 | +1.6% | ₹941.00 | ₹954.40 | ₹925.05 | 30,255 | |
| ₹935.40 | -5.45 | -0.6% | ₹945.55 | ₹957.60 | ₹930.05 | 31,474 | |
| ₹940.85 | +50.60 | +5.7% | ₹900.80 | ₹962.75 | ₹900.80 | 74,301 | |
| ₹890.25 | -22.95 | -2.5% | ₹923.00 | ₹924.65 | ₹885.00 | 74,703 | |
| ₹913.20 | -30.75 | -3.3% | ₹936.90 | ₹936.90 | ₹889.30 | 54,044 | |
| ₹943.95 | +23.75 | +2.6% | ₹942.00 | ₹948.90 | ₹935.35 | 24,866 | |
| ₹920.20 | +7.40 | +0.8% | ₹915.00 | ₹926.95 | ₹905.00 | 19,145 | |
| ₹912.80 | -38.70 | -4.1% | ₹955.70 | ₹956.25 | ₹904.10 | 76,825 | |
| ₹951.50 | +77.00 | +8.8% | ₹879.85 | ₹957.80 | ₹873.60 | 507,810 | |
| ₹874.50 | -32.80 | -3.6% | ₹916.00 | ₹916.00 | ₹871.00 | 35,846 | |
| ₹907.30 | +4.90 | +0.5% | ₹905.60 | ₹919.00 | ₹891.10 | 17,700 | |
| ₹902.40 | +5.50 | +0.6% | ₹903.00 | ₹924.00 | ₹883.80 | 20,438 | |
| ₹896.90 | +11.40 | +1.3% | ₹887.90 | ₹903.90 | ₹882.20 | 22,567 | |
| ₹885.50 | -9.50 | -1.1% | ₹897.40 | ₹902.40 | ₹873.00 | 43,240 | |
| ₹895.00 | -26.20 | -2.8% | ₹923.70 | ₹923.70 | ₹885.00 | 42,724 | |
| ₹921.20 | -18.80 | -2.0% | ₹937.40 | ₹955.00 | ₹908.00 | 26,699 | |
| ₹940.00 | -40.90 | -4.2% | ₹980.00 | ₹981.40 | ₹935.60 | 39,572 | |
| ₹980.90 | -14.90 | -1.5% | ₹996.70 | ₹1,015.00 | ₹961.00 | 68,988 | |
| ₹995.80 | +21.40 | +2.2% | ₹974.40 | ₹999.50 | ₹970.10 | 21,658 | |
| ₹974.40 | -25.40 | -2.5% | ₹1,004.50 | ₹1,004.50 | ₹971.10 | 23,701 | |
| ₹999.80 | +8.90 | +0.9% | ₹989.90 | ₹1,008.90 | ₹980.50 | 24,671 | |
| ₹990.90 | +11.60 | +1.2% | ₹986.30 | ₹998.70 | ₹966.00 | 33,040 | |
| ₹979.30 | -17.10 | -1.7% | ₹1,005.00 | ₹1,014.80 | ₹970.80 | 67,198 | |
| ₹996.40 | -15.80 | -1.6% | ₹1,012.20 | ₹1,017.90 | ₹988.60 | 19,953 | |
| ₹1,012.20 | -17.80 | -1.7% | ₹1,038.40 | ₹1,038.40 | ₹995.20 | 29,610 | |
| ₹1,030.00 | -6.20 | -0.6% | ₹1,035.90 | ₹1,040.00 | ₹1,018.30 | 47,054 | |
| ₹1,036.20 | +18.90 | +1.9% | ₹1,007.40 | ₹1,062.00 | ₹1,005.80 | 67,127 | |
| ₹1,017.30 | +35.10 | +3.6% | ₹990.00 | ₹1,024.10 | ₹977.40 | 60,534 | |
| ₹982.20 | 0.00 | 0.0% | ₹982.20 | ₹982.20 | ₹982.20 | 0 | |
| ₹982.20 | -30.30 | -3.0% | ₹1,016.20 | ₹1,017.90 | ₹975.90 | 80,328 | |
| ₹1,012.50 | -5.60 | -0.6% | ₹1,024.00 | ₹1,030.00 | ₹1,011.00 | 37,182 | |
| ₹1,018.10 | -19.90 | -1.9% | ₹1,045.00 | ₹1,052.40 | ₹1,013.10 | 35,053 | |
| ₹1,038.00 | -22.60 | -2.1% | ₹1,067.80 | ₹1,068.90 | ₹1,029.30 | 28,476 | |
| ₹1,060.60 | -10.40 | -1.0% | ₹1,078.50 | ₹1,080.20 | ₹1,051.00 | 33,156 | |
| ₹1,071.00 | -22.60 | -2.1% | ₹1,091.00 | ₹1,099.00 | ₹1,065.00 | 32,669 | |
| ₹1,093.60 | -7.30 | -0.7% | ₹1,105.90 | ₹1,114.90 | ₹1,084.20 | 27,575 | |
| ₹1,100.90 | -10.10 | -0.9% | ₹1,115.00 | ₹1,125.00 | ₹1,095.20 | 22,809 | |
| ₹1,111.00 | +5.70 | +0.5% | ₹1,109.80 | ₹1,124.90 | ₹1,095.10 | 23,879 | |
| ₹1,105.30 | +3.90 | +0.4% | ₹1,101.90 | ₹1,119.40 | ₹1,093.10 | 25,007 | |
| ₹1,101.40 | +17.40 | +1.6% | ₹1,084.00 | ₹1,115.90 | ₹1,077.00 | 23,453 | |
| ₹1,084.00 | -8.20 | -0.8% | ₹1,092.20 | ₹1,092.20 | ₹1,054.10 | 21,627 | |
| ₹1,092.20 | -38.90 | -3.4% | ₹1,134.80 | ₹1,136.60 | ₹1,076.70 | 49,513 | |
| ₹1,131.10 | 0.00 | 0.0% | ₹1,131.10 | ₹1,131.10 | ₹1,131.10 | 0 | |
| ₹1,131.10 | -18.70 | -1.6% | ₹1,155.90 | ₹1,155.90 | ₹1,117.00 | 22,425 | |
| ₹1,149.80 | -14.10 | -1.2% | ₹1,166.10 | ₹1,175.00 | ₹1,140.00 | 35,996 | |
| ₹1,163.90 | -25.90 | -2.2% | ₹1,185.80 | ₹1,189.80 | ₹1,160.00 | 32,831 | |
| ₹1,189.80 | -29.90 | -2.5% | ₹1,215.00 | ₹1,215.00 | ₹1,172.40 | 30,444 | |
| ₹1,219.70 | 0.00 | 0.0% | ₹1,219.70 | ₹1,219.70 | ₹1,219.70 | 0 | |
| ₹1,219.70 | -17.00 | -1.4% | ₹1,230.00 | ₹1,254.80 | ₹1,214.50 | 48,188 | |
| ₹1,236.70 | +6.10 | +0.5% | ₹1,236.80 | ₹1,254.80 | ₹1,221.20 | 39,179 | |
| ₹1,230.60 | -8.90 | -0.7% | ₹1,235.00 | ₹1,240.80 | ₹1,206.20 | 35,163 | |
| ₹1,239.50 | +36.20 | +3.0% | ₹1,208.60 | ₹1,252.90 | ₹1,198.60 | 66,587 | |
| ₹1,203.30 | -29.50 | -2.4% | ₹1,216.20 | ₹1,234.80 | ₹1,196.60 | 42,877 | |
| ₹1,232.80 | +26.40 | +2.2% | ₹1,206.40 | ₹1,241.00 | ₹1,204.00 | 51,366 | |
| ₹1,206.40 | -42.80 | -3.4% | ₹1,250.00 | ₹1,264.80 | ₹1,200.30 | 64,607 | |
| ₹1,249.20 | +8.30 | +0.7% | ₹1,240.80 | ₹1,255.00 | ₹1,232.30 | 56,086 | |
| ₹1,240.90 | +38.20 | +3.2% | ₹1,212.00 | ₹1,248.00 | ₹1,203.10 | 144,103 | |
| ₹1,202.70 | +76.70 | +6.8% | ₹1,131.60 | ₹1,228.30 | ₹1,125.60 | 360,212 | |
| ₹1,126.00 | +5.50 | +0.5% | ₹1,129.50 | ₹1,135.00 | ₹1,108.60 | 29,039 | |
| ₹1,120.50 | +38.30 | +3.5% | ₹1,087.00 | ₹1,159.00 | ₹1,087.00 | 240,958 |
- Ticker
- BSE:EPIGRAL
- Asset type
- Stock
- Sector
- Chemicals & materials
- Industry
- Chemicals
- Exchange
- BSE
- Currency
- INR
What changed lately
Latest news release · Nov 2, 2026
Epigral Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "UNAUDITED FINANCIAL RESULTS - Q2 FY27".
Latest earnings call · Nov 2, 2026
Epigral (NSE:EPIGRAL) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Nov 2, 2026
Q2 FY2027 Earnings Presentation
Earnings · 42 slides
Latest news
Epigral Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "UNAUDITED FINANCIAL RESULTS - Q2 FY27".
Nov 2, 2026
Closed ₹951.50 (+8.8%) on Nov 2, 2026
Epigral Ltd Press Release Jul 27 2026
Jul 27, 2026
Closed ₹1,157.00 (-0.5%) on Jul 27, 2026
Press Release May 02 2026
May 2, 2026
Closed ₹1,328.70 (+9.3%) on May 4, 2026
Press Release Feb 03 2026
Feb 3, 2026
Closed ₹1,026.60 (-0.7%) on Feb 4, 2026
Press Release Jan 30 2026
Jan 30, 2026
Closed ₹922.80 (-11.5%) on Feb 2, 2026
Epigral Ltd on 6ix
- Sector
- Chemicals & materials
- Industry
- Chemicals
- News releases
- 5 in the last 12 months · 28 in all · newest Nov 2, 2026 · oldest 2021
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 2, 2026
- Decks
- 34 decks · latest Nov 2, 2026
Where Epigral Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:EPIGRAL · Home listing | NSE | India | INR |
| BSE:EPIGRAL · This page | BSE | India | INR |
Valuation
P/E 14.1× against a median of 99.2×: 2nd lowest of 7 Chemicals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹44.75B INR
- P/E
- 14.1×
- EV/sales
- 1.6×
- EV/EBITDA
- 7.6×
- Price/book
- 1.7×
- Gross margin
- 24.1%
- Operating margin
- 14.9%
- Net margin
- 10.2%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Chemicals: the 10 companies nearest in size, of 628 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd · NSE:EPIGRAL | US$432.2M | US$482.9M | 14.1× | 1.6× | 7.6× | 1.7× | 10.2% | 0.2× | n/a |
| Kangda New Materials (Group) Co. Ltd. Class A · SZSE:002669 | US$443.9M | US$470.0M | 28.5× | 0.6× | n/a | 1.1× | 1.8% | 0.3× | n/a |
| Jiangsu Feymer Technology Co., Ltd. Class A · SSE:688350 | US$443.0M | US$437.1M | n/a | 2.1× | n/a | 1.6× | −2.0% | 0.3× | n/a |
| GHCL Limited · NSE:GHCL | US$442.6M | US$335.8M | 7.6× | 1.0× | 4.3× | 1.1× | 17.3% | 0.0× | n/a |
| Shanghai Kinlita Chemical Co., Ltd. Class A · SZSE:300225 | US$441.5M | US$386.3M | 170× | 2.8× | n/a | 3.4× | 1.9% | 0.0× | n/a |
| Everlight Chemical Industrial Corporation · TWSE:1711 | US$439.2M | US$492.7M | 199× | 2.1× | 27.7× | 1.6× | 0.9% | 0.4× | n/a |
| Shanghai Yongguan Adhesive Products Corp., Ltd. Class A · SSE:603681 | US$435.1M | US$348.0M | 21.4× | 0.3× | n/a | 0.8× | 1.9% | 0.1× | n/a |
| Yingkou Fengguang Advanced Material Co. Ltd. Class A · SZSE:301100 | US$434.9M | US$357.9M | n/a | 2.2× | n/a | 1.4× | −2.1% | 0.0× | n/a |
| Jiangsu Yida Chemical Co. Ltd. Class A · SZSE:300721 | US$429.6M | US$415.8M | n/a | 1.3× | n/a | 2.6× | −0.2% | 0.0× | n/a |
| Valhi, Inc. · NYSE:VHI | US$428.5M | US$764.2M | 330× | 0.3× | 3.7× | 0.4× | 0.1% | 0.5× | 0.66 |
| Chemplast Sanmar Limited · NSE:CHEMPLASTS | US$426.6M | US$557.5M | n/a | 1.1× | 52.6× | 2.5× | −7.6% | 1.1× | n/a |
| Median of the others | US$437.2M | US$426.5M | 99.2× | 1.2× | 16.0× | 1.5× | 0.5% | 0.3× | 0.66 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1728.00 INR · Analysts' mean
- EPS, year to Mar 2027
- 80.35 · 2 analysts
- Revenue, year to Mar 2027
- 30.88B · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Kaushal Soparkar | Executive Director |
| Maulik Patel | Chairman & Managing Director |
Board
| Director | Role |
|---|---|
| Ankit Patel | Non-Executive Director |
| Darshan Patel | Non-Executive Director |
| Kanu Patel | Independent Director |
| Karana Patel | Non-Executive Director |
| Kaushal Soparkar | Executive Director |
| Manu Patel | Independent Director |
| Priyanka Chopra | Independent Director |
| Raju Swamy | Independent Director |
| Sanjay Asher | Independent Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Epigral (NSE:EPIGRAL) Q2 2027 Earnings Call | Mon, Nov 02, 2026 · 12:36 PM ET | Replay |
| Epigral (NSE:EPIGRAL) Q1 2027 Earnings Call | Mon, Jul 27, 2026 · 12:55 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2026 | May 2, 2026 · Before open | +9.3% |
| Q2 2026 | Nov 10, 2025 · Before open | −7.3% |
| Q1 2026 | Aug 2, 2025 · Before open | −6.5% |
| Q4 2025 | May 5, 2025 · Before open | +0.9% |
| Q3 2025 | Jan 27, 2025 · Before open | +5.7% |
| Q2 2023 | Oct 20, 2022 · Before open | −5.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 42 slides | Nov 2, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 38 slides | Jul 27, 2026 |
| Q4 FY2026 Earnings Presentation | Earnings | 39 slides | May 2, 2026 |
| Q3 FY2026 Earnings Presentation | Earnings | 39 slides | Jan 30, 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 39 slides | Nov 10, 2025 |
| Q1 FY2026 Earnings Presentation | Earnings | 37 slides | Aug 2, 2025 |
| Q4 FY2025 Earnings Presentation | Earnings | 40 slides | May 5, 2025 |
| Q3 FY2025 Earnings Presentation | Earnings | 41 slides | Jan 27, 2025 |
| Q2 FY2025 Earnings Presentation | Earnings | 41 slides | Nov 9, 2024 |
| Q1 FY2025 Earnings Presentation | Earnings | 36 slides | Jul 24, 2024 |
All 34 decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.0B | 25.5B | 18.9B | 21.7B | 15.5B | 8.26B | 6.10B | 7.10B | 5.97B | 3.92B |
| Cost of revenue | 20.4B | 14.8B | 11.2B | 15.3B | 8.01B | 4.12B | 2.92B | 2.69B | 2.49B | 1.75B |
| Gross profit | 4.63B | 10.7B | 7.79B | 6.43B | 7.48B | 4.13B | 3.18B | 4.41B | 3.49B | 2.17B |
| Research and development | 8.60M | 5.50M | 9.40M | 7.62M | 7.62M | 5.12M | ||||
| Selling, general and administrative | 69.8M | 50.1M | 70.0M | 62.7M | 47.1M | 38.5M | 19.8M | 18.1M | 13.6M | |
| Operating income | 3.82B | 9.52B | 3.33B | 5.68B | 4.24B | 1.88B | 1.54B | 2.59B | 3.19B | 2.02B |
| Depreciation and amortization | 1.68B | 1.33B | 1.24B | 1.09B | 859.1M | 735.4M | 443.0M | 541.0M | 552.7M | 554.3M |
| EBITDA | 5.50B | 10.8B | 4.56B | 6.77B | 5.10B | 2.61B | 1.98B | 3.13B | 3.74B | 2.57B |
| Interest expense | 473.6M | 532.7M | 741.4M | 666.6M | 478.4M | 311.0M | 81.5M | 253.6M | 77.4M | 132.2M |
| Income before tax | 3.41B | 5.41B | 2.91B | 5.22B | 3.83B | 1.61B | 1.41B | 2.42B | 1.95B | 750.5M |
| Income tax | 87.9M | 1.83B | 948.8M | 1.69B | 1.31B | 600.2M | 290.0M | 594.8M | 396.9M | 85.1M |
| Net income | 3.32B | 3.58B | 1.96B | 3.53B | 2.53B | 1.01B | 1.12B | 1.83B | 1.55B | 665.4M |
| Earnings per share, basic | 76.95 | 84.68 | 47.14 | 85.03 | 60.84 | 17.26 | 19.29 | 44.00 | 37.42 | 9.40 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 54.6M | 186.4M | 31.8M | 142.4M | 250.9M | 6.80M | 969.0K | 1.29B | 731.0K | 856.0K |
| Short-term investments | 82.2M | 778.6M | 85.3M | 191.1M | 18.8M | 764.3M | 285.3M | |||
| Receivables | 4.17B | 2.32B | 1.79B | 1.79B | 2.58B | 1.20B | 762.0M | 792.3M | 768.6M | 443.9M |
| Inventory | 3.49B | 3.88B | 2.63B | 2.12B | 1.54B | 539.6M | 480.4M | 406.5M | 296.0M | 281.5M |
| Current assets | 8.27B | 7.75B | 5.02B | 4.19B | 4.47B | 1.81B | 1.32B | 2.54B | 1.87B | 1.11B |
| Total assets | 35.1B | 31.5B | 27.9B | 24.3B | 21.2B | 14.5B | 12.7B | 10.4B | 6.71B | 5.28B |
| Accounts payable | 2.60B | 1.86B | 1.65B | 1.10B | 1.10B | 730.5M | 467.9M | 363.4M | 331.5M | 184.1M |
| Current liabilities | 7.10B | 4.93B | 7.80B | 6.48B | 5.32B | 3.89B | 2.65B | 1.77B | 1.52B | 1.21B |
| Long-term debt | 3.34B | 4.49B | 4.92B | 4.35B | 5.57B | |||||
| Total debt | 5.72B | 5.93B | 9.64B | 8.79B | 9.93B | 5.42B | 5.31B | 3.90B | 742.8M | 1.24B |
| Total liabilities | 12.8B | 12.5B | 15.4B | 13.6B | 14.0B | 7.65B | 6.90B | 5.51B | 1.54B | 1.66B |
| Shareholders' equity | 22.2B | 19.0B | 12.5B | 10.7B | 7.26B | 6.84B | 5.83B | 4.93B | 5.17B | 3.62B |
| Shares outstanding | 43.1M | 42.2M | 41.6M | 41.6M | 41.6M | 58.4M | 58.1M | 41.6M | 41.6M | 70.8M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.88B | 4.41B | 3.98B | 6.26B | 2.84B | 2.29B | 1.65B | 2.61B | 2.25B | 1.38B |
| Capital spending | -3.94B | -1.95B | -3.98B | -4.16B | -4.56B | -1.97B | -3.69B | -3.03B | -1.23B | -349.3M |
| Free cash flow | -65.3M | 2.46B | -7.90M | 2.10B | -1.72B | 324.2M | -2.05B | -412.9M | 1.01B | 1.04B |
| Cash from investing | -3.55B | -2.62B | -4.01B | -4.37B | -4.55B | -1.97B | -3.63B | -2.17B | -1.67B | -628.9M |
| Cash from financing | -457.9M | -1.64B | -76.0M | -2.00B | 1.95B | -319.0M | 694.1M | 850.9M | -583.2M | -760.5M |
| Dividends paid | -183.2M | -418.6M | -251.2M | -242.2M | -168.7M | -153.6M | ||||
| Share buybacks | 0 | -950.0M | -550.0M | -609.2M | 0 | -2.22B | ||||
| Change in cash | -167.3M | 154.6M | -110.6M | -108.5M | 244.1M | 5.83M | -1.29B | 1.29B | -125.0K | -4.80M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Epigral Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "UNAUDITED FINANCIAL RESULTS - Q2 FY27". | Nov 2, 2026 | Results | NSE India |
| Epigral Ltd Press Release Jul 27 2026 | Jul 27, 2026 | Results | NSE India |
| Press Release May 02 2026 | May 2, 2026 | Results | NSE India |
| Press Release Feb 03 2026 | Feb 3, 2026 | Other filings | NSE India |
| Press Release Jan 30 2026 | Jan 30, 2026 | Results | NSE India |
| Press Release Nov 10 2025 | Nov 10, 2025 | Other filings | NSE India |
| Press Release Aug 02 2025 | Aug 2, 2025 | Results | NSE India |
| Press Release May 05 2025 | May 5, 2025 | Results | NSE India |
| Press Release Jan 27 2025 | Jan 27, 2025 | Results | NSE India |
| Press Release Nov 09 2024 | Nov 9, 2024 | Results | NSE India |
All 28 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Jul 24 2024 | Jul 24, 2024 | Results | NSE India |
| Press Release Apr 22 2024 | Apr 22, 2024 | Results | NSE India |
| Press Release Apr 03 2024 | Apr 3, 2024 | Other filings | NSE India |
| Press Release Jan 24 2024 | Jan 24, 2024 | Other filings | NSE India |
| Press Release Nov 20 2023 | Nov 20, 2023 | Operations update | NSE India |
| Press Release Nov 06 2023 | Nov 6, 2023 | Results | NSE India |
| Press Release Aug 06 2023 | Aug 6, 2023 | Results | NSE India |
| Press Release Apr 25 2023 | Apr 25, 2023 | Other filings | NSE India |
| Press Release Jan 19 2023 | Jan 19, 2023 | Other filings | NSE India |
| Press Release Oct 20 2022 | Oct 20, 2022 | Other filings | NSE India |
| Press Release Jul 21 2022 | Jul 21, 2022 | Other filings | NSE India |
| Press Release Jun 01 2022 | Jun 1, 2022 | Other filings | NSE India |
| Press Release May 28 2022 | May 28, 2022 | Other filings | NSE India |
| Press Release Apr 25 2022 | Apr 25, 2022 | Other filings | NSE India |
| Press Release Jan 24 2022 | Jan 24, 2022 | Other filings | NSE India |
| Press Release Nov 11 2021 | Nov 11, 2021 | Other filings | NSE India |
| Press Release Oct 26 2021 | Oct 26, 2021 | Other filings | NSE India |
| Press Release Aug 18 2021 | Aug 18, 2021 | Other filings | NSE India |
Cap table
Built by 6ix from Epigral Ltd’s releases
- Common shares
- 43,141,338
- Fully diluted
- 43,141,338
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 43,141,338 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 43,141,338 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ankit Patel | Non-Executive Director · Since at least Nov 4, 2026 |
| Darshan Patel | Non-Executive Director · Since at least Nov 4, 2026 |
| Kanu Patel | Independent Director · Since at least Nov 6, 2026 |
| Karana Patel | Non-Executive Director · Since at least Nov 4, 2026 |
| Kaushal Soparkar | Executive Director · Since at least Nov 6, 2026 |
| Manu Patel | Independent Director · Since at least Nov 6, 2026 |
| Maulik Patel | Chairman & Managing Director · Since at least Nov 6, 2026 |
| Priyanka Chopra | Independent Director · Since at least Nov 6, 2026 |
| Raju Swamy | Independent Director · Since at least Nov 6, 2026 |
| Sanjay Asher | Independent Director · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Epigral Ltd.